Document is current
Any future updates will be listed below
-
Authors
Galli, Mattia https://orcid.org/0000-0003-3909-182X
Terracina, Sergio https://orcid.org/0000-0002-0748-8825
Schiera, Eleonora https://orcid.org/0009-0000-7801-4646
Mancone, Massimo https://orcid.org/0000-0002-0881-7299
Frati, Luigi https://orcid.org/0000-0003-3941-9055
Angiolillo, Dominick J. https://orcid.org/0000-0001-8451-2131
Pulcinelli, Fabio M. https://orcid.org/0000-0003-2595-396X
-
Funding
Funding for this research was provided by:
Università degli Studi di Roma La Sapienza
- License Information
-
More Information
Article History
Accepted: 9 July 2024
First Online: 6 September 2024
Declarations
:
: MG, ST, ES, MM, LF, FMP declare no competing financial interest. DJA declares that he has received consulting fees or honoraria from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, Novartis, PhaseBio, PLx Pharma, Pfizer, and Sanofi. D.J.A. also declares that his institution has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Idorsia, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions, and the Scott R. MacKenzie Foundation.
